Cargando…

Fenofibrate modified-release pellets with lag phase and high oral bioavailability

PURPOSE: Fenofibrate and statin combination therapy is highly recommended by the current clinical guidelines for treatment of mixed dyslipidemia. In this study, an innovative delayed-release preparation of fenofibrate was designed to reduce the risk of muscle toxicity, caused by simultaneous adminis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fang, Zheng, Xin, Bao, YongChu, Chen, Ting, Zeng, Jia, Xu, XiaoLi, Yan, Chao, Feng, LingLin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307495/ https://www.ncbi.nlm.nih.gov/pubmed/30613135 http://dx.doi.org/10.2147/DDDT.S179266

Ejemplares similares

Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018)

Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica
por: Wang, Zhouhua, et al.
Publicado: (2012)

Oral Modified Release Multiple-Unit Particulate Systems: Compressed Pellets, Microparticles and Nanoparticles
por: Al-Hashimi, Nihad, et al.
Publicado: (2018)

Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation
por: Yousaf, Abid Mehmood, et al.
Publicado: (2015)

Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate
por: Yousaf, Abid Mehmood, et al.
Publicado: (2016)

Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate
por: Bai, Andi, et al.
Publicado: (2018)

The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations
por: Weng, Tengfei, et al.
Publicado: (2014)

Preparation of gastro-resistant pellets containing chitosan microspheres for improvement of oral didanosine bioavailability
por: Severino, Patrícia, et al.
Publicado: (2012)

Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
por: Figari, Giorgia, et al.
Publicado: (2023)

Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica [Erratum]
Publicado: (2013)

In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
por: Lin, You-Meei, et al.
Publicado: (2011)

Design of Oral Sustained-Release Pellets by Modeling and Simulation Approach to Improve Compliance for Repurposing Sobrerol
por: Lu, Chu-Hsun, et al.
Publicado: (2022)

Bioavailability Improvement of Carbamazepine via Oral Administration of Modified-Release Amorphous Solid Dispersions in Rats
por: Li, Houli, et al.
Publicado: (2020)

Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug
por: Mohsin, Kazi, et al.
Publicado: (2016)

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential()()
por: Stalinska, J., et al.
Publicado: (2019)

Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide
por: Cha, Kwang-Ho, et al.
Publicado: (2012)

Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study
por: Dian, Linghui, et al.
Publicado: (2013)

Preparation and pharmacokinetics in beagle dogs of ganershu sustained-release pellets
por: Pan, Jin-huo, et al.
Publicado: (2014)

Aminoclay–lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption
por: Yang, Liang, et al.
Publicado: (2016)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

Formulation and evaluation of olanzapine matrix pellets for controlled release
por: Vishal Gupta, N., et al.
Publicado: (2011)

Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
por: Xu, Lei, et al.
Publicado: (2021)

Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation
por: Lee, Jaehyeok, et al.
Publicado: (2022)

Performance of Bituminous Binder Modified with Recycled Plastic Pellets
por: Soliman, Haithem, et al.
Publicado: (2023)

Development of an oral push–pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles
por: Zhao, Zongzhe, et al.
Publicado: (2015)

Measuring dissolution profiles of single controlled-release drug pellets
por: Bhakta, Heran C., et al.
Publicado: (2020)

Analgesia Effect of Enteric Sustained-Release Tetrodotoxin Pellets in the Rat
por: Hong, Bihong, et al.
Publicado: (2020)

On the duration of the microbial lag phase
por: Vermeersch, Lieselotte, et al.
Publicado: (2019)

Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability
por: Real, Daniel Andrés, et al.
Publicado: (2021)

Novel Sustained-Release of Propafenone through Pellets: Preparation and in Vitro/in Vivo Evaluation
por: Zhang, Li, et al.
Publicado: (2014)

Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form
por: Lam, Matthew, et al.
Publicado: (2019)

Preparation, characterization and relative bioavailability of oral elemene o/w microemulsion
por: Zeng, Zhaowu, et al.
Publicado: (2010)

Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension
por: Abdelkader, Hamdy, et al.
Publicado: (2023)

Preparation and evaluation of Vinpocetine self-emulsifying pH gradient release pellets
por: Liu, Mengqi, et al.
Publicado: (2017)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010)

Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats
por: Park, Mi-Kyoung, et al.
Publicado: (2012)

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010)

Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets
por: Zakowiecki, Daniel, et al.
Publicado: (2021)

Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics
por: Ahmed, Osama AA, et al.
Publicado: (2015)

Optimization and control in bacterial Lag phase
por: Schultz, Daniel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bh4sice6l73n0ig76vaulbjahf